Short form of the 'WAIS-III for use with patients with schizophrenia

被引:167
作者
Blyler, CR [1 ]
Gold, JM [1 ]
Iannone, VN [1 ]
Buchanan, RW [1 ]
机构
[1] Univ Maryland, Maryland Psychiat Res Ctr, Catonsville, MD 21228 USA
关键词
full-scale IQ; schizophrenia; short form WAIS-III;
D O I
10.1016/S0920-9964(00)00017-7
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The recent publication of the Wechsler Adult Intelligence Scale (WAIS-III), the most widely used standard test of intelligence, requires the development of a new short fc,rm for use with patients with schizophrenia for many clinical and research purposes. We used regression analyses of complete WAIS-III data on 41 outpatients with schizophrenia and 41 education-, and age-matched healthy subjects to determine the best combination of subtests to use as a short form. Excluding three subtests that are time-consuming to administer, and requiring that the solution includes one subtest from each of the four WAIS index scores, the combination that most fully accounted for the variance in full-scale IQ (FSIQ) for both participants with schizophrenia (R-2=0.90) and healthy controls (R-2=0.86) included the information, block design, arithmetic, and digit symbol subtests. When the restrictions regarding which subtests could enter were relaxed, the best four-subtest solution included information, block design, comprehension, and similarities. Although the latter explained 95% of the variance in FSIQ for schizophrenia participants and 90% of the variance for healthy controls, it consistently overestimated FSIQ for the schizophrenia group. We recommend the four-factor short form for use in future research and clinical practice in which a quick, accurate IQ estimate is desired. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:209 / 215
页数:7
相关论文
共 50 条
  • [21] Validity and usefulness of the short form of the Drinking Motives Questionnaire Revised (DMQ-R SF) among patients with schizophrenia
    Gierski, Fabien
    Benzerouk, Farid
    Jeanblanc, Jerome
    Angerville, Bernard
    Dervaux, Alain
    Kaladjian, Arthur
    Naassila, Mickael
    ADDICTIVE BEHAVIORS, 2022, 129
  • [22] QLiS-SF: Development of a short form of the quality of life in schizophrenia questionnaire
    Senin, T.
    Franz, M.
    Deuschle, M.
    Bergemann, N.
    Kammerer-Ciernioch, J.
    Lautenschlager, M.
    Meyer, T.
    BMC PSYCHIATRY, 2017, 17
  • [23] QLiS-SF: Development of a short form of the quality of life in schizophrenia questionnaire
    T. Senin
    M. Franz
    M. Deuschle
    N. Bergemann
    J. Kammerer-Ciernioch
    M. Lautenschlager
    T. Meyer
    BMC Psychiatry, 17
  • [24] Short communication: Genetic association between schizophrenia and cannabis use
    Verweij, Karin J. H.
    Abdellaoui, Abdel
    Nivard, Michel G.
    Cort, Alberto Sainz
    Ligthart, Lannie
    Draisma, Harmen H. M.
    Minica, Camelia C.
    Gillespie, Nathan A.
    Willemsen, Gonneke
    Hottenga, Jouke-Jan
    Boomsma, Dorret I.
    Vink, Jacqueline M.
    DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : 117 - 121
  • [25] Evaluation on Long-Term Test-Retest Reliability of the Short-Form Childhood Trauma Questionnaire in Patients with Schizophrenia
    Xiang, Zhibiao
    Liu, Zhening
    Cao, Hengyi
    Wu, Zhipeng
    Long, Yicheng
    PSYCHOLOGY RESEARCH AND BEHAVIOR MANAGEMENT, 2021, 14 : 1033 - 1040
  • [26] Craving in Patients With Schizophrenia and Cannabis Use Disorders
    Schnell, Thomas
    Becker, Theresa
    Thiel, Maria Chantal
    Gouzoulis-Mayfrank, Euphrosyne
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2013, 58 (11): : 646 - 649
  • [27] Perspectives on the Use of eHealth in the Management of Patients With Schizophrenia
    Treisman, Glenn J.
    Jayaram, Geetha
    Margolis, Russell L.
    Pearlson, Godfrey D.
    Schmidt, Chester W.
    Mihelish, Gary L.
    Kennedy, Adrienne
    Howson, Alexandra
    Rasulnia, Maziar
    Misiuta, Iwona E.
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2016, 204 (08) : 620 - 629
  • [28] The reasons for use of cannabinoids and stimulants in patients with schizophrenia
    Simonienko, Katarzyna
    Wygnal, Natalia
    Cwalina, Urszula
    Kwiatkowski, Mikolaj
    Szulc, Agata
    Waszkiewicz, Napoleon
    PSYCHIATRIA POLSKA, 2018, 52 (02) : 261 - 273
  • [29] Insight and use of health resources in patients with schizophrenia
    Haro, JM
    Ochoa, S
    Cabrero, L
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2001, 29 (02): : 103 - 108
  • [30] Prevalence of Substance Use in Patients Diagnosed with Schizophrenia
    Tekin Uludag, Yasemin
    Gulec, Gulcan
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2016, 53 (01): : 4 - 11